Vimarsana
Biggest News Aggregation in the World

Page 46 - Platform Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Platform Technology Today - Breaking & Trending Today

Schroders UK Platform Awards: Winners revealed! - Vimarsana News

Schroders UK Platform Awards: Winners revealed!

Here they are... the winners at the 2022 Schroders UK Platform Awards.

$20 Million Sale of Partial IP Asset Sale plus Strong Financial Growth with Projected Acceleration: Stock Symbol: CURR - Vimarsana News

$20 Million Sale of Partial IP Asset Sale plus Strong Financial Growth with Projected Acceleration: Stock Symbol: CURR

$20 Million Cash Gain from Partial IP Asset Sale and Strong Financial Growth with Projected Acceleration: CURE Pharmaceutical: (Stock Symbol: CURR)

Synaffix Wins 'Best ADC Platform Technology' Award Again at World ADC Awards Ceremony 2022 - Vimarsana News

Synaffix Wins 'Best ADC Platform Technology' Award Again at World ADC Awards Ceremony 2022

Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announces that the Company was awarded ‘Best ADC Platform Technology’ at the World ADC Conference 2022. This ...

Conserving Supply of Personal Protective Equipment—A Call for Ideas - Vimarsana News

Conserving Supply of Personal Protective Equipment—A Call for Ideas

The editors of JAMA recognize the challenges, concerns, and frustration about the shortage of personal protective equipment (PPE) that is affecting the care of

Synaffix Wins 'Best ADC Platform Technology' Award Again at World ADC Awards Ceremony 2022 - Vimarsana News

Synaffix Wins 'Best ADC Platform Technology' Award Again at World ADC Awards Ceremony 2022

/PRNewswire/ -- Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug...